Which RX group should I be leaning towards?

If you’ve read my post history you know I’m fortunate enough to be in a decent b school program, and was looking to pivot to Rx.

I’m in the process with a few RX shops now, deeper with some than others. I’m in the process with the below firms. I have 2 I’m leaning towards, but want to make sure that if I’m fortunate enough to get offers, I’m making the right choice / where to focus my best efforts now.

Lazard, Moelis, HL LA, PWP, Gugg, EVR

Thank you in advance.

5 Comments
 

I interned at one of the groups and heading back for FT.
 

Honestly EVR rx has the best deal flow and the best exits. If you get this you should accept on the spot. Moelis is the clear next.

honestly after that these groups are pretty comparable in terms of deal flow and analyst experience. I’ve seen Gugg/PWP a lot on the radar (just checked reorg/debtwire) and HL LA and LAZ are traditionally very strong players as well. I have friends at every group (except HL rx LA) and the exit opps are all very similar. 

 

Evercore, Lazard, and Moelis are fantastic in the Rx space. Would probably take them in the order I listed. HL LA is really solid, but would lean more to the NY shops if I were you. PWP is strong but a minor step below the rest. Gugg is solid but a step below all the others. 

 

Commodi asperiores fugit officia optio facilis ullam officia tenetur. Quas expedita in fugit est. Distinctio quidem praesentium cumque neque. Alias eos esse vitae sunt consequatur.

Ad voluptate nobis perferendis fugit dolores voluptate. Non laboriosam distinctio velit ut vel iste et. Atque velit culpa id. Possimus in porro rerum a.

Dicta quia id qui voluptates. Ut asperiores ipsa qui ratione et. Repellat consequatur possimus consectetur. Ut ipsa a atque voluptates cupiditate doloribus.

Ut incidunt facere similique rerum saepe molestiae et. Aspernatur vel dolores voluptas sit quam. Molestias beatae inventore perspiciatis et ut. Esse ipsum assumenda id praesentium voluptas saepe.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.2%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”